Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.
Journal: JAMA network open
Published: July 14, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.
Journal: Substance use & misuse
Published: April 03, 2026
Care trajectories among people with opioid use disorder after release from New York City jails: A state sequence analysis approach.
Journal: Drug and alcohol dependence
Published: October 29, 2025
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone.
Journal: Journal of addiction medicine
Published: August 12, 2025
Opioid Use Disorder Outcomes Following Inpatient Opioid Withdrawal Management.
Journal: Journal of addiction medicine
Published: June 20, 2025
Identifying patterns of withdrawal among patients in treatment for opioid use disorder: A secondary latent class growth analysis of the CTN XBOT trial.
Journal: Journal of substance use and addiction treatment
Published: April 07, 2025
Injectable buprenorphine during transition out of prison: A pilot partially randomized preference trial protocol.
Journal: Contemporary clinical trials
Published: March 29, 2025
Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC).
Journal: Health & justice
Published: December 20, 2024
The Polysubstance Assessment Tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use.
Journal: Addiction (Abingdon, England)
Published: November 20, 2024
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data.
Journal: Addiction (Abingdon, England)
Published: September 17, 2024
Provider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods survey.
Journal: Journal of substance use
Published: July 15, 2024
Last Updated: 09/26/2026